THERMOGENESIS HOLDINGS INC (THMO) Stock Price & Overview

NASDAQ:THMO • US88362L2097

Current stock price

0.3102 USD
-0.11 (-25.84%)
At close:
0.3161 USD
+0.01 (+1.9%)
After Hours:

The current stock price of THMO is 0.3102 USD. Today THMO is down by -25.84%. In the past month the price decreased by -40.41%. In the past year, price decreased by -76.85%.

THMO Key Statistics

52-Week Range0.3101 - 1.82
Current THMO stock price positioned within its 52-week range.
1-Month Range0.3101 - 0.875
Current THMO stock price positioned within its 1-month range.
Market Cap
2.466M
P/E
N/A
Fwd P/E
1.52
EPS (TTM)
-4.28
Dividend Yield
N/A

THMO Stock Performance

Today
-25.84%
1 Week
-46.52%
1 Month
-40.41%
3 Months
-59.13%
Longer-term
6 Months -57.51%
1 Year -76.85%
2 Years -97.50%
3 Years -99.74%
5 Years N/A
10 Years N/A

THMO Stock Chart

THERMOGENESIS HOLDINGS INC / THMO Daily stock chart

THMO Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to THMO. When comparing the yearly performance of all stocks, THMO is a bad performer in the overall market: 97.96% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

THMO Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to THMO. THMO may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

THMO Earnings

On May 17, 2024 THMO reported an EPS of -0.46 and a revenue of 2.74M. The company missed EPS expectations (-4609.8% surprise) and missed revenue expectations (-29.39% surprise).

Next Earnings DateAug 8, 2024
Last Earnings DateMay 17, 2024
PeriodQ1 / 2024
EPS Reported-$0.46
Revenue Reported2.737M
EPS Surprise -4,609.80%
Revenue Surprise -29.39%

THMO Forecast & Estimates

7 analysts have analysed THMO and the average price target is 5.1 USD. This implies a price increase of 1544.1% is expected in the next year compared to the current price of 0.3102.

For the next year, analysts expect an EPS growth of 102.13% and a revenue growth 48.46% for THMO


Analysts
Analysts82.86
Price Target5.1 (1544.1%)
EPS Next Y102.13%
Revenue Next Year48.46%

THMO Groups

Sector & Classification

Index Membership

THMO Financial Highlights

Over the last trailing twelve months THMO reported a non-GAAP Earnings per Share(EPS) of -4.28. The EPS increased by 76.7% compared to the year before.


Income Statements
Revenue(TTM)9.60M
Net Income(TTM)-14.75M
Industry RankSector Rank
PM (TTM) N/A
ROA -146.23%
ROE -1512.82%
Debt/Equity 4.31
Chartmill High Growth Momentum
EPS Q2Q%-15233.33%
Sales Q2Q%6.42%
EPS 1Y (TTM)76.7%
Revenue 1Y (TTM)-7.66%

THMO Ownership

Ownership
Inst Owners0.02%
Shares7.95M
Float3.51M
Ins OwnersN/A
Short Float %0.01%
Short Ratio0

About THMO

Company Profile

THMO logo image ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California and currently employs 40 full-time employees. The company provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and the CAR-TXpress platform for large scale cell manufacturing services. Its products include Clinical Bio-Banking Applications, Point-of-Care Applications and Large-Scale Cell Processing and Biomanufacturing. Its Clinical Bio-Banking Applications include AXP Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Its Large-Scale Cell Processing and Biomanufacturing includes X-Series Products for general laboratory use and CAR-TXpress Platform for Clinical Manufacturing. AXP Automated Cell Separation System is an automated, fully closed cell separation system.

Company Info

IPO: 1987-06-05

THERMOGENESIS HOLDINGS INC

2711 Citrus Rd

Rancho Cordova CALIFORNIA 95742 US

CEO: Chris Xu

Employees: 40

THMO Company Website

Phone: 19168585100

THERMOGENESIS HOLDINGS INC / THMO FAQ

What does THERMOGENESIS HOLDINGS INC do?

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California and currently employs 40 full-time employees. The company provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and the CAR-TXpress platform for large scale cell manufacturing services. Its products include Clinical Bio-Banking Applications, Point-of-Care Applications and Large-Scale Cell Processing and Biomanufacturing. Its Clinical Bio-Banking Applications include AXP Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Its Large-Scale Cell Processing and Biomanufacturing includes X-Series Products for general laboratory use and CAR-TXpress Platform for Clinical Manufacturing. AXP Automated Cell Separation System is an automated, fully closed cell separation system.


Can you provide the latest stock price for THERMOGENESIS HOLDINGS INC?

The current stock price of THMO is 0.3102 USD. The price decreased by -25.84% in the last trading session.


Does THERMOGENESIS HOLDINGS INC pay dividends?

THMO does not pay a dividend.


What is the ChartMill technical and fundamental rating of THMO stock?

THMO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Which stock exchange lists THMO stock?

THMO stock is listed on the Nasdaq exchange.


What is the employee count for THMO stock?

THERMOGENESIS HOLDINGS INC (THMO) currently has 40 employees.


Who owns THERMOGENESIS HOLDINGS INC?

You can find the ownership structure of THERMOGENESIS HOLDINGS INC (THMO) on the Ownership tab.